NCT00934063View on ClinicalTrials.gov

An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2013

Study Completion Date

June 30, 2014

Conditions
Growth Hormone DisorderAdult Growth Hormone Deficiency
Interventions
DRUG

somatropin

For s.c. (under the skin) injection. Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

OTHER

No treatment given

Control group not receiving treatment

Trial Locations (1)

55127

Mainz

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY